Related references
Note: Only part of the references are listed.Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
Francesca Megiorni et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling
Styliani Karanika et al.
CELL REPORTS (2017)
Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells
C. Antinozzi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells
Francesco Marampon et al.
CANCER LETTERS (2017)
Human rhabdomyosarcoma cells express functional pituitary and gonadal sex hormone receptors: therapeutic implications
Agata Poniewierska-Baran et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population
Carmela Ciccarelli et al.
MOLECULAR CANCER (2016)
Pubertal development and regulation
Ana Paula Abreu et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Insulin-Like Growth Factor System in Cancer: Novel Targeted Therapies
Varsha P. Brahmkhatri et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Testosterone treatment increases androgen receptor and aromatase gene expression in myotubes from patients with PCOS and controls, but does not induce insulin resistance
Mette Brandt Eriksen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members
Francesca Megiorni et al.
BMC CANCER (2014)
Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay
Francesco Marampon et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Radiation-induced signaling pathways that promote cancer cell survival (Review)
Ashley L. Hein et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer
Giovanni Luca Gravina et al.
ENDOCRINE-RELATED CANCER (2013)
Down-Regulation of the Oncogene Cyclin D1 Increases Migratory Capacity in Breast Cancer and Is Linked to Unfavorable Prognostic Features
Sophie Lehn et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Essential Role for p38α MAPK But Not p38γ MAPK in Igf2 Expression and Myoblast Differentiation
Fiona A. Lovett et al.
ENDOCRINOLOGY (2010)
Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells-identification of a novel androgen response element
Marilena Lanzino et al.
NUCLEIC ACIDS RESEARCH (2010)
Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients
Iyad Sultan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma
Francesco Marampon et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Androgen-Responsive Gene Database: Integrated Knowledge on Androgen-Responsive Genes
Mei Jiang et al.
MOLECULAR ENDOCRINOLOGY (2009)
Non-genomic actions of androgens
C. D. Foradori et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2008)
Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors
Francesco Marampon et al.
MOLECULAR CANCER (2006)
Androgen effects on hippocampal CA1 spine synapse numbers are retained in Tfm male rats with defective androgen receptors
NJ MacLusky et al.
ENDOCRINOLOGY (2006)
p21WAF1 Expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells
Carmela Ciccarelli et al.
MOLECULAR CANCER (2005)
Testosterone action on skeletal muscle
KL Herbst et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2004)
Minireview: Cyclin D1: Normal and abnormal functions
MF Fu et al.
ENDOCRINOLOGY (2004)
Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells
R Fukuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Adult rhabdomyosarcoma - Outcome following multimodality treatment
DJ Little et al.
CANCER (2002)
Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function
MF Fu et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation
MF Fu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Modeling of circadian testosterone in healthy men and hypogonadal men
SK Gupta et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
